MP35-16 DOES FEMINIZING HORMONE THERAPY REDUCE ACE2 RECEPTOR EXPRESSION?: A HISTOLOGIC STUDY USING TRANSGENDER WOMEN’S TESTICLE TISSUE AFTER ORCHIECTOMY, AND, IMPLICATIONS FOR POSSIBLE USE FOR COVID19 TREATMENT AND/OR PREVENTION
John M. Masterson(Cedars-Sinai Medical Center), Maurice M. Garcia(Cedars-Sinai Medical Center), Wohaib Hasan(Cedars-Sinai Medical Center), Xiaopen Yuan(Cedars-Sinai Medical Center), Warren G. Tourtellotte(Cedars-Sinai Medical Center), Daniel Luthringer(Cedars-Sinai Medical Center), Yi Zhang(Beijing Normal-Hong Kong Baptist University), Harneet Jawanda(Cedars-Sinai Medical Center), Chau M. Bui(Cedars-Sinai Medical Center), Carissa A. Huynh(Cedars-Sinai Medical Center)
Cited by 1
Related Papers
Bax-Deficient Mice with Lymphoid Hyperplasia and Male Germ Cell Death
|Science|1995|1.5k
The EGR family of transcription-regulatory factors: progress at the interface of molecular and systems neuroscience
|Trends in Neurosciences|1999|461
Metformin inhibition of mitochondrial ATP and DNA synthesis abrogates NLRP3 inflammasome activation and pulmonary inflammation
|Immunity|2021|409
Myofibroblasts in Murine Cutaneous Fibrosis Originate From Adiponectin‐Positive Intradermal Progenitors
|Arthritis & Rheumatology|2014|334
Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3
|Nature Genetics|1998|309